The S-Phase Arrest of Host Cells Caused by an Alpha-Herpesvirus Genome Replication Facilitates Viral Recruitment of RNA Polymerase II to Transcribe Viral Genes

Abstract

Herpesviruses rely on host RNA polymerae II (RNA Pol II) for their mRNA transcription, yet the mechanisms of which has been poorly defined, while certain herpesviruses can enhance viral gene transcription by altering the RNA Pol II location, modulating its phosphorylation, or directly interacting with RNA Pol II. However, the influence of herpesviruses on RNA Pol II transcription extends beyond these direct effects. Here, we present a novel mechanism by which the host cell cycle regulates viral gene transcription via RNA Pol II during infection by Anatid Herpesvirus 1 (AnHV-1), an avian alpha-herpesvirus. The results demonstrated that the formation of viral replication compartments (vRCs) and the subsequent recruitment of RNA pol II are positively correlated with AnHV-1 DNA synthesis. As viral DNA replication progresses, host cells are arrested in the S phase, which not only halts host gene transcription but also facilitates viral transcription. This cell cycle arrest in the S phase promotes viral DNA (vDNA) synthesis and vRC formation, which further enhances the preferential recruitment of RNA Pol II to viral promoters, enabling efficient viral gene transcription. We propose that this S phase arrest and the hijacking of RNA Pol II represent a novel mechanism by which AnHV-1 enhances viral transcription, offering a unique survival strategy compared to the known strategy in herpesviruses. These findings expand our understanding of herpesvirus–host interactions and highlight potential targets for antiviral strategies.

Keywords

AnHV-1 / cell cycle / gene transcription / genome replication / RNA polymerase II

References

[1] E. K. Flemington, “Herpesvirus Lytic Replication and the Cell Cycle: Arresting New Developments,” Journal of Virology 75 (2001): 4475-4481.

[2] J. Gil-Ranedo, E. Hernando, L. Riolobos, C. Domínguez, M. Kann, and J. M. Almendral, “The Mammalian Cell Cycle Regulates Parvovirus Nuclear Capsid Assembly,” PLoS Pathogens 11 (2015): e1004920.

[3] P. Xu, Z. Zhou, M. Xiong, et al., “Parvovirus B19 NS1 Protein Induces Cell Cycle Arrest at G2-Phase by Activating the ATR-CDC25C-CDK1 Pathway,” PLoS Pathogens 13 (2017): e1006266.

[4] C. H. Birkenheuer, C. G. Danko, and J. D. Baines, “Herpes Simplex Virus 1 Dramatically Alters Loading and Positioning of RNA Polymerase II on Host Genes Early in Infection,” Journal of Virology 92 (2018): e02184-17.

[5] K. A. Fraser and S. A. Rice, “Herpes Simplex Virus Type 1 Infection Leads to Loss of Serine-2 Phosphorylation on the Carboxyl-Terminal Domain of RNA Polymerase II,” Journal of Virology 79 (2005): 11323-11334.

[6] K. A. Fraser and S. A. Rice, “Herpes Simplex Virus Immediate-Early Protein ICP22 Triggers Loss of Serine 2-Phosphorylated RNA Polymerase II,” Journal of Virology 81 (2007): 5091-5101.

[7] C. A. Spencer, M. E. Dahmus, and S. A. Rice, “Repression of Host RNA Polymerase II Transcription by Herpes Simplex Virus Type 1,” Journal of Virology 71 (1997): 2031-2040.

[8] J. Q. Dai-Ju, L. Li, L. A. Johnson, and R. M. Sandri-Goldin, “ICP27 Interacts With the C-Terminal Domain of RNA Polymerase II and Facilitates Its Recruitment to Herpes Simplex Virus 1 Transcription Sites, Where It Undergoes Proteasomal Degradation During Infection,” Journal of Virology 80 (2006): 3567-3581.

[9] M. C. Long, V. Leong, P. A. Schaffer, C. A. Spencer, and S. A. Rice, “ICP22 and the UL13 Protein Kinase Are Both Required for Herpes Simplex Virus-Induced Modification of the Large Subunit of RNA Polymerase II,” Journal of Virology 73 (1999): 5593-5604.

[10] S. A. Rice, M. C. Long, V. Lam, P. A. Schaffer, and C. A. Spencer, “Herpes Simplex Virus Immediate-Early Protein ICP22 Is Required for Viral Modification of Host RNA Polymerase II and Establishment of the Normal Viral Transcription Program,” Journal of Virology 69 (1995): 5550-5559.

[11] H. Qi, M. Yin, F. Xiong, et al., “ICP22-Defined Condensates Mediate RNAPII Deubiquitylation by UL36 and Promote HSV-1 Transcription,” Cell Reports 43 (2024): 114792.

[12] A. F. Castañeda, A. L. Didychuk, R. K. Louder, et al., “The Gammaherpesviral TATA-Box-Binding Protein Directly Interacts With the CTD of Host RNA pol II to Direct Late Gene Transcription,” PLoS Pathogens 16 (2020): e1008843.

[13] Y. C. Perng, J. A. Campbell, D. J. Lenschow, and D. Yu, “Human Cytomegalovirus pUL79 Is an Elongation Factor of RNA Polymerase II for Viral Gene Transcription,” PLoS Pathogens 10 (2014): e1004350.

[14] D. Bose, R. K. Singh, and E. S. Robertson, “KSHV-Encoded LANA Bypasses Transcriptional Block Through the Stabilization of RNA pol II in Hypoxia,” MBio 15 (2024): e0277423.

[15] S. J. Bark-Jones, H. M. Webb, and M. J. West, “EBV EBNA 2 Stimulates CDK9-Dependent Transcription and RNA Polymerase II Phosphorylation on Serine 5,” Oncogene 25 (2006): 1775-1785.

[16] S. M. Amie, E. Noble, and B. Kim, “Intracellular Nucleotide Levels and the Control of Retroviral Infections,” Virology 436 (2013): 247-254.

[17] S. Bagga and M. J. Bouchard, “Cell Cycle Regulation During Viral Infection,” Methods in Molecular Biology (Clifton, N.J.) 1170 (2014): 165-227.

[18] W. A. Bresnahan, I. Boldogh, E. A. Thompson, and T. Albrecht, “Human Cytomegalovirus Inhibits Cellular DNA Synthesis and Arrests Productively Infected Cells in Late G1,” Virology 224 (1996): 150-160.

[19] D. Dittmer and E. S. Mocarski, “Human Cytomegalovirus Infection Inhibits G1/S Transition,” Journal of Virology 71 (1997): 1629-1634.

[20] M. Lu and T. Shenk, “Human Cytomegalovirus Infection Inhibits Cell Cycle Progression at Multiple Points, Including the Transition From G1 to S,” Journal of Virology 70 (1996): 8850-8857.

[21] B. S. Salvant, E. A. Fortunato, and D. H. Spector, “Cell Cycle Dysregulation by Human Cytomegalovirus: Influence of the Cell Cycle Phase at the Time of Infection and Effects on Cyclin Transcription,” Journal of Virology 72 (1998): 3729-3741.

[22] P. Kumar and C. Wood, “Kaposi's Sarcoma-Associated Herpesvirus Transactivator Rta Induces Cell Cycle Arrest in G0/G1 Phase by Stabilizing and Promoting Nuclear Localization of p27kip,” Journal of Virology 87 (2013): 13226-13238.

[23] X. Liu and J. I. Cohen, “Varicella-Zoster Virus ORF12 Protein Activates the Phosphatidylinositol 3-Kinase/Akt Pathway to Regulate Cell Cycle Progression,” Journal of Virology 87 (2013): 1842-1848.

[24] L. Trapp-Fragnet, D. Bencherit, D. Chabanne-Vautherot, et al., “Cell Cycle Modulation by Marek's Disease Virus: The Tegument Protein VP22 Triggers S-Phase Arrest and DNA Damage in Proliferating Cells,” PLoS One 9 (2014): e100004.

[25] J. E. Packard and J. A. Dembowski, “HSV-1 DNA Replication-Coordinated Regulation by Viral and Cellular Factors,” Viruses 13 (2021): 2015.

[26] T. J. Taylor, E. E. McNamee, C. Day, and D. M. Knipe, “Herpes Simplex Virus Replication Compartments Can Form by Coalescence of Smaller Compartments,” Virology 309 (2003): 232-247.

[27] E. Caragliano, W. Brune, and J. B. Bosse, “Herpesvirus Replication Compartments: Dynamic Biomolecular Condensates?,” Viruses 14 (2022): 960.

[28] M. Weidner-Glunde, G. Mariggiò, and T. F. Schulz, “Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen: Replicating and Shielding Viral DNA During Viral Persistence,” Journal of Virology 91 (2017): 10-1128.

[29] M. Charman and M. D. Weitzman, “Replication Compartments of DNA Viruses in the Nucleus: Location, Location, Location,” Viruses 12 (2020): 151.

[30] L. Chang, W. J. Godinez, I. H. Kim, et al., “Herpesviral Replication Compartments Move and Coalesce at Nuclear Speckles to Enhance Export of Viral Late mRNA,” Proceedings of the National Academy of Sciences of the United States of America 108 (2011): 136-144.

[31] A. de Bruyn Kops and D. M. Knipe, “Formation of DNA Replication Structures in Herpes Virus-Infected Cells Requires a Viral DNA Binding Protein,” Cell 55 (1988): 857-868.

[32] R. D. Everett, G. Sourvinos, and A. Orr, “Recruitment of Herpes Simplex Virus Type 1 Transcriptional Regulatory Protein ICP4 Into Foci Juxtaposed to ND10 in Live, Infected Cells,” Journal of Virology 77 (2003): 3680-3689.

[33] H. L. Jenkins and C. A. Spencer, “RNA Polymerase II Holoenzyme Modifications Accompany Transcription Reprogramming in Herpes Simplex Virus Type 1-Infected Cells,” Journal of Virology 75 (2001): 9872-9884.

[34] L. R. Overby, R. G. Duff, and J. C. Mao, “Antiviral Potential of Phosphonoacetic Acid,” Annals of the New York Academy of Sciences 284 (1977): 310-320.

[35] Y. Guo, A. Cheng, M. Wang, et al., “Development of TaqMan® MGB Fluorescent Real-Time PCR Assay for the Detection of Anatid Herpesvirus 1,” Virology Journal 6 (2009): 1-8.

[36] M. Seyffert, F. Georgi, K. Tobler, et al., “The HSV-1 Transcription Factor ICP4 Confers Liquid-Like Properties to Viral Replication Compartments,” International Journal of Molecular Sciences 22 (2021): 4447.

[37] C. A. Smith, P. Bates, R. Rivera-Gonzalez, B. Gu, and N. A. DeLuca, “ICP4, the Major Transcriptional Regulatory Protein of Herpes Simplex Virus Type 1, Forms a Tripartite Complex With TATA-Binding Protein and TFIIB,” Journal of Virology 67 (1993): 4676-4687.

[38] R. B. Tunnicliffe, M. P. Lockhart-Cairns, C. Levy, et al., “The Herpes Viral Transcription Factor ICP4 Forms a Novel DNA Recognition Complex,” Nucleic Acids Research 45 (2017): 8064-8078.

[39] K. C. Dudas and W. T. Ruyechan, “Identification of a Region of the Herpes Simplex Virus Single-Stranded DNA-Binding Protein Involved in Cooperative Binding,” Journal of Virology 72 (1998): 257-265.

[40] C. J. Lukonis and S. K. Weller, “Formation of Herpes Simplex Virus Type 1 Replication Compartments by Transfection: Requirements and Localization to Nuclear Domain 10,” Journal of Virology 71 (1997): 2390-2399.

[41] S. L. Uprichard and D. M. Knipe, “Assembly of Herpes Simplex Virus Replication Proteins at Two Distinct Intranuclear Sites,” Virology 229 (1997): 113-125.

[42] T. J. Taylor and D. M. Knipe, “Proteomics of Herpes Simplex Virus Replication Compartments: Association of Cellular DNA Replication, Repair, Recombination, and Chromatin Remodeling Proteins With ICP8,” Journal of Virology 78 (2004): 5856-5866.

[43] M. Simpson-Holley, R. C. Colgrove, G. Nalepa, J. W. Harper, and D. M. Knipe, “Identification and Functional Evaluation of Cellular and Viral Factors Involved in the Alteration of Nuclear Architecture During Herpes Simplex Virus 1 Infection,” Journal of Virology 79 (2005): 12840-12851.

[44] E. A. Bowman and W. G. Kelly, “RNA Polymerase II Transcription Elongation and pol II CTD Ser2 Phosphorylation: A Tail of Two Kinases,” Nucleus 5 (2014): 224-236.

[45] J. P. Hsin and J. L. Manley, “The RNA Polymerase II CTD Coordinates Transcription and RNA Processing,” Genes & Development 26 (2012): 2119-2137.

[46] J. Yockteng-Melgar, K. Shire, A. Z. Cheng, N. Malik-Soni, R. S. Harris, and L. Frappier, “G(1)/S Cell Cycle Induction by Epstein-Barr Virus BORF2 Is Mediated by P53 and APOBEC3B,” Journal of Virology 96 (2022): e0066022.

[47] P. Lomonte, and R. D. Everett, “Herpes Simplex Virus Type 1 Immediate-Early Protein Vmw110 Inhibits Progression of Cells Through Mitosis and From G (1) Into S Phase of the Cell Cycle,” Journal of Virology 73 (1999): 9456-9467.

[48] W. E. Hobbs and N. A. DeLuca, “Perturbation of Cell Cycle Progression and Cellular Gene Expression as a Function of Herpes Simplex Virus ICP0,” Journal of Virology 73 (1999): 8245-8255.

[49] B. Bogdanow, Q. V. Phan, and L. Wiebusch, “Emerging Mechanisms of G (1)/S Cell Cycle Control by Human and Mouse Cytomegaloviruses,” MBio 12 (2021): e0293421.

[50] F. M. Jault, J. M. Jault, F. Ruchti, et al., “Cytomegalovirus Infection Induces High Levels of Cyclins, Phosphorylated Rb, and p53, Leading to Cell Cycle Arrest,” Journal of Virology 69 (1995): 6697-6704.

[51] J. D. Oduro, R. Uecker, C. Hagemeier, and L. Wiebusch, “Inhibition of Human Cytomegalovirus Immediate-Early Gene Expression by Cyclin A2-Dependent Kinase Activity,” Journal of Virology 86 (2012): 9369-9383.

[52] B. Bogdanow, M. Schmidt, H. Weisbach, et al., “Cross-Regulation of Viral Kinases With Cyclin A Secures Shutoff of Host DNA Synthesis,” Nature Communications 11 (2020): 4845.

[53] J. Bartek and J. Lukas, “Chk1 and Chk2 Kinases in Checkpoint Control and Cancer,” Cancer Cell 3 (2003): 421-429.

[54] D. Santamaría, C. Barrière, A. Cerqueira, et al., “Cdk1 Is Sufficient to Drive the Mammalian Cell Cycle,” Nature 448 (2007): 811-815.

[55] C. S. Sørensen and R. G. Syljuåsen, “Safeguarding Genome Integrity: The Checkpoint Kinases ATR, CHK1 and WEE1 Restrain CDK Activity During Normal DNA Replication,” Nucleic Acids Research 40 (2012): 477-486.

[56] S. Tadesse, A. T. Anshabo, N. Portman, et al., “Targeting CDK2 in Cancer: Challenges and Opportunities for Therapy,” Drug Discovery Today 25 (2020): 406-413.

[57] B. T. Hughes, J. Sidorova, J. Swanger, R. J. Monnat, and B. E. Clurman, “Essential Role for Cdk2 Inhibitory Phosphorylation During Replication Stress Revealed by a Human Cdk2 Knockin Mutation,” Proceedings of the National Academy of Sciences of the United States of America 110 (2013): 8954-8959.

[58] M. Kõivomägi, M. P. Swaffer, J. J. Turner, G. Marinov, and J. M. Skotheim, “G (1) Cyclin-Cdk Promotes Cell Cycle Entry Through Localized Phosphorylation of RNA Polymerase II,” Science (New York, N.Y.) 374 (2021): 347-351.

[59] M. Sansó and R. P. Fisher, “Pause, Play, Repeat: CDKs Push RNAP II's Buttons,” Transcription 4 (2013): 146-152.

[60] C. Gilbert, J. Bestman-Smith, and G. Boivin, “Resistance of Herpesviruses to Antiviral Drugs: Clinical Impacts and Molecular Mechanisms,” Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy 5 (2002): 88-114.

[61] H. H. Schalkwijk, R. Snoeck, and G. Andrei, “Acyclovir Resistance in Herpes Simplex Viruses: Prevalence and Therapeutic Alternatives,” Biochemical Pharmacology 206 (2022): 115322.

[62] P. K. Parua and R. P. Fisher, “Dissecting the pol II Transcription Cycle and Derailing Cancer With CDK Inhibitors,” Nature Chemical Biology 16 (2020): 716-724.

[63] D. Li, W. Fu, and S. Swaminathan, “Continuous DNA Replication Is Required for Late Gene Transcription and Maintenance of Replication Compartments in Gammaherpesviruses,” PLoS Pathogens 14 (2018): e1007070.

[64] J. Chen, K. Ueda, S. Sakakibara, et al., “Activation of Latent Kaposi's Sarcoma-Associated Herpesvirus by Demethylation of the Promoter of the Lytic Transactivator,” Proceedings of the National Academy of Sciences of the United States of America 98 (2001): 4119-4124.

[65] M. Szyf, L. Eliasson, V. Mann, G. Klein, and A. Razin, “Cellular and Viral DNA Hypomethylation Associated With Induction of Epstein-Barr Virus Lytic Cycle,” Proceedings of the National Academy of Sciences of the United States of America 82 (1985): 8090-8094.

[66] R. Hollingworth, R. D. Horniblow, C. Forrest, G. S. Stewart, and R. J. Grand, “Localization of Double-Strand Break Repair Proteins to Viral Replication Compartments Following Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus,” Journal of Virology 91 (2017): 10-1128.

RIGHTS & PERMISSIONS

2025 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.